Discussing the finer points of AI as a catalyst for pharmaceutical innovation

Cancer vaccines are compelling but there are challenges that must be faced. Experts give their view.

An interview with Debra Weiss, Chief Operating Officer at the Bill & Melinda Gates Medical Research Institute.

We dive into the archive of 2023 for insight and inspiration – this time with Carl June.

What’s all this talk of cancer vaccines? We find out how they work – and how mRNA has boosted the field – with the help of five experts.

We need to step away from assumptions on device interchangeability and find out what patients really want.

Why GLP-1 anti-obesity drugs are taking the market by storm.

The repurposing of legacy small molecules drugs could be more advantageous than previously known. Case in point: Arsenic

We dive into the archive of 2020 for insight and inspiration – this time with Jane Osbourn.

Patient needs are changing, but small molecule drugs remain as important as ever. Here are some tips for development success.